Novel Discorhabdin Derivatives from Antarctic Sponges of the Genus Latrunculia: Expanding the Chemical Diversity of Polar Marine Natural Products
Marine Drugs · 2025
DOI: 10.3390/md23100401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Sam Afoullouss und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, CHE205, Tampa, FL 33620, USA. Hauptthemen laut MEDLINE: Porifera, Biological Products, Antineoplastic Agents, Pyrroloiminoquinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: US National Science Foundation, NIH HHS, ACE Foundation and Ferring Pharmaceuticals.
Abstract (Originalsprache)
In this study, three Antarctic sponges of the genus Latrunculia were investigated, leading to the isolation of five unreported pyrroloiminoquinone alkaloids along with the known metabolite (+)-debromodiscorhabdin A (3). Three of the new metabolites were brominated, while the other two were found to have a C-5/C-8 sulfur bridge and a C-2/N-18 bridge. Three of the metabolites were shown to have a phenyl ketone substituent on C-14, not previously reported for discorhabdin derivatives. The cytotoxicity against the A549 cell lines was studied and compounds 1–4 showed activity of 4.3, 1.8, 1.0, and 23.9 µM, respectively, while no inhibition was found for 5 and 6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, CHE205, Tampa, FL 33620, USA.
- School of Biological Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
- Collections & Research, Western Australian Museum, 49 Kew Street, Welshpool, WA 6106, Australia.
ORCID-Profile: Sam Afoullouss, Stine S H Olsen, Nerida G Wilson, Bill J Baker
Förderung
- US National Science Foundation
- NIH HHS
- ACE Foundation and Ferring Pharmaceuticals
- NIAID NIH HHS
- NCCIH NIH HHS
- US National Institutes of Health
- National Science Foundation
- Swiss Polar Institute
Zitieren
APA
Afoullouss, S., Olsen, S. S. H., Morrow, S., Cruz Rosa, E., Geu, K., Wilson, N. G., & Baker, B. J. (2025). Novel Discorhabdin Derivatives from Antarctic Sponges of the Genus Latrunculia: Expanding the Chemical Diversity of Polar Marine Natural Products. Marine Drugs. https://doi.org/10.3390/md23100401
Vancouver
Afoullouss S, Olsen SSH, Morrow S, Cruz Rosa E, Geu K, Wilson NG, et al. Novel Discorhabdin Derivatives from Antarctic Sponges of the Genus Latrunculia: Expanding the Chemical Diversity of Polar Marine Natural Products. Marine Drugs. 2025. doi:10.3390/md23100401
BibTeX
@article{Afoullouss2025,
author = {Afoullouss, Sam and Olsen, Stine S H and Morrow, Sydney and Cruz Rosa, Ezequiel and Geu, Kaley and Wilson, Nerida G and Baker, Bill J},
title = {Novel Discorhabdin Derivatives from Antarctic Sponges of the Genus Latrunculia: Expanding the Chemical Diversity of Polar Marine Natural Products},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23100401}
}
EUVIMED